South Carolina has been provided with a limited supply of Remdesivir, the drug that recently received an emergency use authorization by the U.S. Food and Drug Administration (FDA) for treating patients with COVID-19. The FDA states that the investigational drug was shown during a clinical trial to shorten the recovery time in some COVID-19 patients. Since then, the pharmaceutical company Gilead Sciences donated vials of Remdesivir to the U.S….
More Stories
Brazil rolls out COVID-19 vaccination plan
First Pfizer COVID-19 vaccine shipments to be delivered to US distribution sites starting Monday
CDC advisory panel recommends Covid-19 vaccine for people 16 and over